Cuba and Roswell Park Cancer Institute will extend collaboration
Biotechnology collaboration being developed between Cuba and the Roswell Park Cancer Institute of the United States (RPCI) may be extended until November 30, 2027, by the renewal of the license from the authorities of the northern country.